Development of tetracycline-modified nanoparticles for bone-targeted delivery of anti-tubercular drug

Background: Since the poor response to existing anti-tuberculosis drugs and low drug concentration in local bone tissues, the traditional drug therapy does not result in satisfactory treatment of osteoarticular tuberculosis. Thus, we report a rifapentine release system with imparted bone targeting p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Qiuzhen, Zhang, Pengfei, Zhang, Liang, Luan, Haopeng, Li, Xinxia, Xiang, Haibin, Jing, Shuang, Song, Xinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450143/
https://www.ncbi.nlm.nih.gov/pubmed/37635999
http://dx.doi.org/10.3389/fbioe.2023.1207520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450143/
https://www.ncbi.nlm.nih.gov/pubmed/37635999
http://dx.doi.org/10.3389/fbioe.2023.1207520

Ejemplares similares